The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 842.00
Bid: 844.00
Ask: 846.00
Change: 4.00 (0.48%)
Spread: 2.00 (0.237%)
Open: 845.00
High: 847.00
Low: 839.00
Prev. Close: 838.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Interim Update and Notice of Results

22 Jul 2022 07:00

RNS Number : 3704T
JTC PLC
22 July 2022
 

22 July 2022

 

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Pre-close Interim Trading Update and Notice of Results

 

Record new business growth, acquisitions integrating well and strong cash generation

 

 

JTC, the global professional services business, today issues the following trading update in advance of its interim results for the period ended 30 June 2022.

 

The first half of the year has seen a strong performance across the Group, with the Company delivering within all of its well-established guidance metrics, namely, 8% - 10% net organic revenue growth, underlying EBITDA margin of 33% - 38%, with margin progression compared to 2021, demonstrating the Group's ability to manage higher cost inflation. Cash conversion was within the guidance range of 85% - 90% and as a result, leverage reduced by 0.7 times in the period, bringing it well within guidance of 1.5 - 2.0 times underlying EBITDA.

 

Organic growth was driven by record new business wins of £12.6m (+22% on H1 2021 figure of £10.3m) with a new business pipeline at period end of £52.2m (+15% on the H1 2021 figure of £45.3m). Performance in June was strong, giving good momentum into H2, demonstrating JTC's highly resilient business model and the long-term structural growth drivers of the sector.

 

In terms of inorganic growth, the seven businesses acquired in 2021 are all integrating well onto the JTC global platform and the M&A pipeline remains active with a number of small to mid-size opportunities well progressed. Targets span both the Institutional Clients Services Division (fund and corporate services) and the Private Client Services Division (trust company and family office services) with a particular focus on the high-growth, US market.

 

The Board is confident that the Group will deliver full year results in line with market expectations* and maintains its medium-term guidance.

 

*analyst consensus as published by JTC at: https://www.jtcgroup.com/investor-relations/analyst-consensus/ 

 

Nigel Le Quesne, CEO of JTC PLC, said:

 

"In the first half of 2022 we have built upon the strong performance delivered in 2021. The business continues to demonstrate its resilience and agility during a period of macro uncertainty and our record new business wins reflect our ability to attract new clients and provide additional services to existing clients as they navigate both the threats and opportunities presented by the wider markets. All integration programmes for the businesses we acquired in 2021 are on track and we maintain a healthy pipeline of targets in a consolidating sector. We look forward to capitalising on our momentum in the second half of the year and, as always, my thanks go to the outstanding global team of JTC employee-owners, who continue to deliver service excellence for our clients and drive the Group forwards."

 

 

Notice of Results

 

The Company will announce its interim results for the period ended 30 June 2022 on Tuesday 13 September 2022. An analyst briefing will be given by Nigel Le Quesne, Chief Executive Officer, and Martin Fotheringham, Chief Financial Officer, at 09:30 BST via audio conference.

 

Slides and an audio-cast of the presentation will be made available on the JTC website following the presentation. Those analysts wishing to dial into the audio conference are asked to contact Camarco on +44 (0)20 3757 4999 or jtc@camarco.co.uk

 

 

Enquiries:

JTC PLC +44 (0) 1534 700 000

Nigel Le Quesne, Chief Executive Officer

Martin Fotheringham, Chief Financial Officer

David Vieira, Chief Communications Officer

 

Camarco +44 (0) 20 3757 4985

Geoffrey Pelham-Lane

Georgia Edmonds

Sam Morris

 

About JTC

JTC is a publicly listed, global professional services business with deep expertise in fund, corporate and private client services. Every JTC person is an owner of the business and this fundamental part of our culture aligns us with the best interests of all of our stakeholders. Our purpose is to maximise potential and our success is built on service excellence, long-term relationships and technology capabilities that drive efficiency and add value. 

www.jtcgroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEEFAFEESELW
Date   Source Headline
24th Apr 20247:00 amRNSPDMR Shareholding
22nd Apr 20243:51 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSAcquisition of First Republic Trust Co of Delaware
18th Apr 20247:00 amRNSAnnual Financial Report and Notice of AGM
10th Apr 20247:00 amRNSVesting and Grant of Share Plan Awards
9th Apr 20247:00 amRNSFull year results for year ended 31 December 2023
20th Mar 20245:59 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSCompletion of Acquisition and Issue of Equity
29th Feb 202410:33 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSPre-close Full Year Trading Update
31st Jan 20247:00 amRNSTotal Voting Rights
12th Jan 20247:00 amRNSPayment of SALI earnout and issue of equity
12th Dec 20234:39 pmRNSTR1: Notification of Major Holdings
7th Dec 20237:00 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSAcquisition of Blackheath Capital Management LLP
22nd Nov 202310:22 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSHolding(s) in Company
25th Sep 20237:00 amRNSDirector's Share Dealing
19th Sep 20237:00 amRNSPDMR's Share Dealing
12th Sep 20237:00 amRNSInterim results for the period ended 30 June 2023
1st Sep 20239:00 amRNSTotal Voting Rights
10th Aug 202310:42 amRNSHolding(s) in Company
9th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSCompletion of SDTC Acquisition and Issue of Equity
25th Jul 20237:00 amRNSInterim Trading Update and Notice of Results
21st Jun 20237:00 amRNSIssue of Equity and Voting Rights
20th Jun 20239:43 amRNSHolding(s) in Company
15th Jun 20237:00 amRNSResults of Placing
14th Jun 20234:36 pmRNSProposed Placing of New Ordinary Shares
14th Jun 20234:35 pmRNSAcquisition of South Dakota Trust Company
9th Jun 20239:43 amRNSHolding(s) in Company
31st May 20237:00 amRNSTotal Voting Rights
24th May 20238:12 amRNSResult of AGM
4th May 20237:00 amRNSIssue of Equity and Voting Rights
21st Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
12th Apr 20237:00 amRNSVesting and Grant of Performance Share Plan Awards
11th Apr 20237:00 amRNSFull year results for year ended 31 December 2022
7th Mar 20231:57 pmRNSHolding(s) in Company
13th Feb 202312:08 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSPre-close Full Year Trading Update
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20222:52 pmRNSFormation of Governance and Risk Committee
1st Nov 20227:00 amRNSCompletion of NYPTC Acquisition
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
26th Aug 20227:00 amRNSProposed Acquisition of NYPTC
27th Jul 20227:00 amRNSEIP Award Vesting
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.